HOME > TOP STORIES
TOP STORIES
-
REGULATORY MHLW Calls for Revision of Package Inserts for SGLT-2 Inhibitors
January 13, 2015
-
ORGANIZATION Price Grouping Rule Triggered “Distortion” in Generic Market: JGA President
January 9, 2015
-
REGULATORY 30% R&D Tax Deduction Cap Could Be Secured with Open Innovation Tax Break: Economic Affairs Division
January 8, 2015
-
REGULATORY Public Trust Indispensable for Industry Development: Mr Futagawa of Health Policy Bureau
January 7, 2015
-
REGULATORY Pharmaceutical and Food Safety Bureau to Promote Prescription-to-OTC Switches Based on Industry Opinions
January 6, 2015
-
ORGANIZATION FPMAJ Chairman Wishes for Good Environment for Drug Innovation in 2015
January 1, 2015
-
TRENDS ARBs at a Turning Point: Inroads by Generics to Lead to Gradual Decline in Sales
December 26, 2014
-
REGULATORY LDP Study Group Shows Sense of Crisis over Reduction of R&D Tax Deduction Cap
December 25, 2014
-
ORGANIZATION FPMAJ “Hasn’t Given Up” on Maintenance of 30% R&D Tax Deduction Cap: Chairman
December 24, 2014
-
ORGANIZATION EFPIA Japan Chairman Calls for More Rewards for Innovation
December 22, 2014
-
BUSINESS Takeda Names Sanofi’s Plump as New R&D Head
December 19, 2014
-
BUSINESS Daiichi Sankyo Looks to Bring Annual 8-10 Projects into Clinical Phase, Open Innovation Key to Success: R&D Execs
December 18, 2014
-
BUSINESS CRO Intellim to Collaborate with Indian Firm for CDISC
December 18, 2014
-
REGULATORY LDP Tax Panel Execs Eye Slight Cut of R&D Tax Deduction Cap
December 17, 2014
-
BUSINESS Battle Begins for Blopress Generics
December 16, 2014
-
REGULATORY LDP Healthcare Big Names Cruise to Victory in Lower House Poll
December 15, 2014
-
REGULATORY Outline of New Global Clinical Trial Guidelines Agreed On at ICH Confab in Lisbon
December 12, 2014
-
REGULATORY Elplat, Elaspol Generics to Join NHI Price List on Dec. 12
December 11, 2014
-
REGULATORY Annual NHI Price Cuts Draw Fire from All Sides at Ryukaikon Council
December 10, 2014
-
REGULATORY Japan NIH to Have Drug Discovery Support Unit
December 9, 2014
ページ
On paper, things should be looking up for Japan’s pharmaceutical wholesalers. Industry expectations are mounting that the average gap between NHI and market prices will narrow further in FY2026 from the previous year’s record low of 4.8%.A shrinking gap should…
Tariffs have been a defining feature of US trade policy under President Donald Trump’s second administration. Since Trump unveiled his “reciprocal” tariff policy in April 2025, the landscape has shifted repeatedly.In February 2026, the US Supreme Court invalidated tariffs imposed…
